1[1]Robbins BL,Srinivas RV,Kim C,et al.Anti-human immunodeficiency virus activity and cellular metabolism of a potential prodrug of the acyclic nucleoside phosphonate 9-R-(2-phosphonomethoxypropyl)adenine (PMPA),Bis(isopropyloxymethylcarbonyl)PMPA[J].Antimicrob Agents Chemother,1998,42(3):612-617.
2[2]Arimilli MN,Kim CU,Dougherty J,et al.Synthesis,in vitro biological evaluation and oral bioavailability of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) prodrugs[J].Antivir Chem Chemother,1997,8(6):557-564.
3[3]Hossain MM,Coull JJ,Drusano GL,et al.Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir,didanosine,and tenofovir[J].Antiviral Res,2002,55(1):41-52.
4[4]Cihlar T,Ho ES,Lin DC,et al.Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs[J].Nucleosides Nucleic Acids,2001,20(4-7):641-648.
5[5]Zidek Z,Frankova D,Holy A.Activation by 9-(R)-[2-(phosphonomethoxy)propyl]adenine of chemokine (RANTES,macrophage inflammatory protein 1α) and cytokine (tumor necrosis factor α,interleukin-10[IL-10],IL-1β) production[J].Antimicrob Agents Chemother,2001,45(12):3381-3386.
6[6]Van Gelder J,Deferme S,Annaert P,et al.Increased absorption of the antiviral ester prodrug tenofovir disoproxil in rat ileum by inhibiting its intestinal metabolism[J].Drug Metab Dispos,2000,28(12):1394-1396.
7[7]Barditch-Crovo P,Deeks SG,Collier A,et al.Phase Ⅰ/Ⅱ trial of the pharmacokinetics,safety,and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults[J].Antimicrob Agents Chemother,2001,45(10):2733-2739.
8[8]Schooley RT,Ruane P,Myers RA,et al.Tenofovir DF in antiretroviral-experienced patients:results from a 48-week,randomized,double-blind study[J].AIDS,2002,16(9):1257-1263.
7Gracey DM,Snelling P,Mc Kenzie P,et al.Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection[J].Antivir Ther,2013,18(7):945-948.
8Verhelst D,Monge M,Meynard JL,et al.Fanconi syndrome and renal failure induced by tenofovir:a first case report[J].Am J Kidney Dis,2002,40(6):1331-1333.
9Hall AM.Update on tenofovir toxicity in the kidney[J].Pediatr Nephrol,2013,28(7):1011-1023.
10Woodward CL,Hall AM,Williams IG,et al.Tenofovir-associated renal and bone toxicity[J].HIV Medicine,2009,10(8):482-487.
